D. Patel, “Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in Treatment of Patients With Polycystic Ovary Syndrome: A Systemic Review of Metabolic and Cardiovascular Outcomes”, Journal For International Medical Graduates, vol. 3, no. 1, Feb. 2024, doi: 10.56570/jimgs.v1i1.149.